New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export TVRD’s income statement to Excel — free account
Tvardi Therapeutics, Inc.
TVRDTvardi Therapeutics, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $7.1 million, down 66.0% from fiscal 2023.
- Revenue
- +20.3%
- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
0.99
0.04
+4.21%
After hours trading: 0.97, down 2.02%, last trade Fri 7:28pm Eastern.
Follow TVRD
Alert me
Ratios over time FY16 to FY25
Returns on capital
ROIC was 0.00% in FY25, against a low of −421.8% in FY22. ROE, at 51.9%, is far above it because equity is small against the capital the business uses.
ROEROIC
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| ROE | −73.5% | −84.5% | −67.2% | −66.4% | 3.9% | −37.1% | −44.2% | −109.8% | 172.7% | 51.9% |
| ROIC | 0.0% | 0.0% | 0.0% | −199.1% | 4.7% | −89.2% | −421.8% | 0.0% | 0.0% | 0.0% |
Debt
Net debt is 1.15× a year’s EBITDA.
Net debt / EBITDA
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net debt / EBITDA | 1.0× | 1.6× | 2.1× | 1.4× | −27.0× | 1.9× | 1.7× | 0.8× | 0.0× | 1.1× |
Cash cycle, in days
Customers pay in 230 days, inventory is held 530 days and suppliers are paid in 1287. Suppliers fund 527 days of working capital.
Days to pay suppliersDays to be paid
| FY21 | FY22 | FY24 | |
|---|---|---|---|
| Cash cycle | −696 | −324 | −527 |
| Days to pay suppliers | 1321 | 482 | 1287 |
| Days to be paid | 18 | 39 | 230 |
Per share, from FY16
Since FY16, per share: revenue has grown 49.1% a year.
RevenueBook value
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.0× | 9.3× | 119.1× | 147.9× | 904.1× | 144.1× | 247.5× | 122.8× | 24.4× |
| Book value | 1.0× | 1.5× | 2.0× | 2.4× | 2.8× | 2.4× | 1.6× | 0.6× | −0.5× |
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 4 | 4 | 2 | 5 | 2 | 3 | 2 | 3 | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 168.02 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z-Score |
5.96 | 18.28 | 2.27 | 5.64 | 18.74 | 15.90 | 9.99 | (9.42) | (5.15) | — |
P/S ratio |
3,094.60 | 401.66 | 32.43 | 34.55 | 5.31 | 4.57 | 14.03 | 1.95 | 6.62 | — |
Altman Z″-Score (non-manufacturers) |
(5.24) | 3.24 | (0.91) | (1.13) | 11.49 | 7.60 | (1.01) | (18.63) | (10.69) | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
(20.18) | (35.09) | (19.14) | (22.05) | 8.74 | (495.98) | (24.99) | (2.36) | (9.78) | — |
Beneish M-Score |
67.91 | 5.26 | 12.86 | (1.55) | 1.40 | (2.84) | (1.22) | (3.39) | (3.66) | — |
P/B ratio |
5.25 | 4.61 | 3.49 | 3.68 | 2.88 | 2.71 | 3.70 | 0.72 | 0.00 | — |
Price to Tangible BV |
5.25 | 4.61 | 3.49 | 3.68 | 2.88 | 2.71 | 3.70 | 0.72 | 0.00 | — |
EV/Sales |
2,408.83 | 308.81 | 21.18 | 26.93 | 4.00 | 3.35 | 10.55 | (2.87) | 6.43 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 82.36 | 0.00 | 0.00 | 0.50 | 0.00 | — |
EV/Operating CF |
(4.37) | (5.62) | (13.66) | (4.90) | (98.38) | (7.53) | (5.61) | 0.65 | (2.51) | — |
EV/FCF |
(4.31) | (5.61) | (13.62) | (4.90) | (92.50) | (7.53) | (5.61) | 0.64 | (2.14) | — |
Quick Ratio |
5.20 | 10.98 | 4.04 | 3.66 | 9.90 | 9.55 | 6.41 | 4.11 | 3.48 | 2.79 |
Current Ratio |
5.33 | 11.18 | 4.16 | 3.86 | 10.55 | 9.84 | 7.20 | 4.54 | 3.06 | 2.86 |
Net Debt/EBITDA |
1.03 | 1.55 | 2.05 | 1.35 | (27.04) | 1.91 | 1.70 | 0.85 | 0.05 | 1.15 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 1.44% | 1.35% | 0.78% | 0.00% | 0.00% | 85.97% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | (0.33) | 0.00 |
Asset Turnover |
0.00 | 0.01 | 0.09 | 0.09 | 0.54 | 0.09 | 0.20 | 0.14 | 0.09 | — |
Operating CF/Net income |
0.83 | 0.94 | 0.30 | 1.03 | (0.65) | 0.68 | 0.92 | 0.78 | 0.62 | 1.29 |
Capex/Depreciation |
(0.57) | 0.20 | 0.05 | 0.03 | (0.30) | 0.01 | (0.02) | (1.23) | (11.01) | 0.00 |
| (73.54%) | (84.54%) | (67.16%) | (66.41%) | 3.86% | (37.12%) | (44.25%) | (109.80%) | 172.69% | 51.90% | |
| (65.57%) | (72.28%) | (51.43%) | (50.20%) | 3.34% | (34.13%) | (39.82%) | (76.94%) | (36.51%) | (54.15%) | |
ROIC |
0.00% | 0.00% | 0.00% | (199.09%) | 4.69% | (89.22%) | (421.75%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(111.17%) | (66.26%) | (57.57%) | (86.16%) | 4.74% | (56.58%) | (58.59%) | (126.23%) | (137.35%) | (88.64%) |
Average Days of Receivables |
3,985.29 | 342.16 | 43.09 | 32.80 | 5.58 | 18.26 | 38.82 | 69.93 | 229.88 | — |
Research and Development Expense of Revenue |
57,270.93% | 5,326.45% | 560.78% | 572.36% | 79.84% | 359.13% | 219.45% | 517.50% | 331.37% | — |
Selling, General and Administrative Expense of Revenue |
10,736.05% | 1,303.18% | 113.74% | 89.23% | 16.17% | 127.71% | 72.27% | 132.48% | 62.45% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
3,255.81% | 635.89% | 70.37% | 63.20% | 10.98% | 90.26% | 42.36% | 65.48% | 4.47% | — |
Graham Net Nets |
0.18 | 0.21 | 0.24 | 0.17 | 0.24 | 0.25 | 0.25 | 1.16 | (2.00) | — |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 117.46 | 0.00 | 0.00 | 0.00 | 95.34 | — |
Earnings Yield |
(21.53%) | (14.88%) | (15.85%) | (15.46%) | 0.60% | (14.21%) | (14.53%) | (288.35%) | (62.17%) | — |
Free Cash Flow Yield |
(18.07%) | (13.70%) | (4.80%) | (15.90%) | (0.81%) | (9.73%) | (13.41%) | (230.65%) | (45.36%) | — |
Revenue per Share |
0.11 | 1.05 | 13.52 | 16.79 | 102.61 | 16.35 | 28.09 | 13.94 | 2.77 | — |
Operating CF per Share |
(62.56) | (63.29) | (22.38) | (92.20) | (4.17) | (42.67) | (52.83) | (61.23) | (7.11) | (3.17) |
Capex per Share |
(0.95) | (0.02) | (0.07) | (0.02) | (0.27) | 0.02 | (0.03) | (1.58) | (0.41) | 0.00 |
Free Cash Flow per Share |
(63.50) | (63.31) | (22.45) | (92.21) | (4.43) | (42.65) | (52.86) | (62.81) | (7.52) | (3.17) |
Cash per Share |
77.87 | 106.86 | 162.31 | 130.84 | 137.44 | 118.62 | 97.84 | 67.27 | 12.28 | 4.15 |
Shareholders Equity per Share |
66.97 | 100.17 | 134.10 | 157.60 | 189.15 | 161.57 | 106.55 | 37.96 | (35.40) | 2.82 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
66.97 | 100.17 | 134.10 | 157.60 | 189.15 | 161.57 | 106.55 | 37.96 | (35.40) | 2.82 |
Free Cash Flow |
(48.10) | (54.84) | (22.37) | (109.24) | (5.84) | (60.06) | (78.77) | (94.45) | (19.35) | (23.50) |
Working Capital |
49.91 | 86.55 | 127.69 | 122.76 | 176.58 | 155.67 | 145.45 | 90.57 | 21.32 | 20.50 |
Capital Expenditures |
(0.72) | (0.02) | (0.07) | (0.02) | (0.35) | 0.03 | (0.04) | (2.37) | (1.05) | — |
Net Current Asset Value |
48.34 | 84.83 | 110.95 | 119.41 | 172.91 | 153.76 | 145.45 | 47.40 | (94.64) | 20.41 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 100.24 | 0.00 | 0.00 | 0.50 | 0.00 | — |
Capex to Sales |
8.34 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.15 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 133.16 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.77 | (0.07) | (1.65) | (0.83) | 1.39 | 3.83 | 4.54 | 0.58 | 1.13 | (2.02) |
Cash ROIC |
(43.84%) | (30.58%) | (7.57%) | (31.66%) | (1.35%) | (15.15%) | (25.86%) | (59.69%) | 66.14% | (45.40%) |
Accounts Receivable Turnover |
0.12 | 1.02 | 11.02 | 11.78 | 70.15 | 14.32 | 14.94 | 4.95 | 1.68 | — |
Accounts Payable Turnover |
— | — | — | — | — | 0.30 | 0.95 | — | 0.11 | — |
Inventory Turnover |
— | — | — | — | — | — | 2.93 | 2.37 | 0.33 | — |
Average Days of Payables |
— | — | — | — | — | 1,321.19 | 482.45 | — | 1,286.92 | — |
Days of Inventory on Hand |
— | — | — | — | — | 606.92 | 119.71 | 166.77 | 529.84 | — |
Average Receivables |
0.70 | 0.90 | 1.22 | 1.69 | 1.93 | 1.61 | 2.80 | 4.24 | 4.26 | — |
Average Payables |
4.28 | 4.28 | 4.10 | 6.74 | 7.00 | 5.26 | 7.61 | — | 5.90 | 2.70 |
Average Inventory |
— | — | — | — | — | — | 2.48 | 2.60 | 1.86 | — |
Average Assets |
87.36 | 80.42 | 143.91 | 211.89 | 252.06 | 259.11 | 214.65 | 154.04 | 80.52 | 33.64 |
Average Common Equity |
77.88 | 68.75 | 110.21 | 160.17 | 217.86 | 238.26 | 193.15 | 107.93 | (17.02) | (35.09) |
Columns are period end dates · fundamentals updated Nov 17, 2026